Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma
Top Cited Papers
- 25 January 2013
- journal article
- research article
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 15 (2), 220-226
- https://doi.org/10.1016/j.jmoldx.2012.10.002
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic MelanomaDiagnostic Molecular Pathology, 2012
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- BRAF targeted therapy changes the treatment paradigm in melanomaNature Reviews Clinical Oncology, 2011
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerProceedings of the National Academy of Sciences of the United States of America, 2010
- Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Journal of Translational Medicine, 2010
- Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body siteMolecular Oncology, 2007
- Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant MelanomaThe Journal of Molecular Diagnostics, 2007
- Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous MelanomasClinical Cancer Research, 2004
- Mutations of the BRAF gene in human cancerNature, 2002